About Us

Established in 2006, Polgenix, Inc., is a small biotech company, whose aims encompass two areas:

1. Drug discovery targeting G protein-coupled receptors (GPCRs) to treat common blinding diseases

2. Innovative high-resolution retinal imaging for ophthalmic drug discovery  


Our Team:


Richard Sutkus, Ph.D., CEO

Krzysztof Palczewski, Ph.D., Chief Scientific Officer

Vida M. Tripodo, Director of Finance & Administration


Science Team:

Grazyna Palczewska, Ph.D., Director of Medical Device Development

David Salom, Ph.D., Scientist

Wenyu Sun, Ph.D., Scientist

Zhiqian Dong, M.D., Ph.D., Research Scientist